STO:CEVI
CellaVision AB (publ) · STO · Healthcare · SEK · FY for 2025
Figures on this page computed 2026-11-08 02:32 UTC
Last close
n/aSEK
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
31.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
22.0%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
20.2%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
23.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
0.03Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
1.3%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Price is the furthest below its sector's middle: 0.25 against 0.36 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.45x
Its own average over 10 years, 523.7M.
- Profit1.42x
Its own average over 10 years, 107.5M.
- Free cash flow1.93x
Its own average over 10 years, 93.9M.
- Debt0.38x
Its own average over 10 years, 67.4M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 1.93 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 116.7 | 116.6 | 100.0 |
| 2018-12-31 | 137.6 | 148.3 | 100.0 |
| 2019-12-31 | 174.2 | 165.8 | 100.0 |
| 2020-12-31 | 177.9 | 149.6 | 100.0 |
| 2021-12-31 | 213.4 | 209.6 | 100.0 |
| 2022-12-31 | 241.2 | 197.9 | 100.0 |
| 2023-12-31 | 255.5 | 217.9 | 100.0 |
| 2024-12-31 | 272.9 | 235.3 | 100.0 |
| 2025-12-31 | 286.4 | 256.0 | 100.0 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SEK
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SEK
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SEK
Figures behind the shape
Growth
10.0%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate10.0%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Five-year EPS growth rate11.3%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
One-year change in net income8.8%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Returns on capital
22.0%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital22.0%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity17.3%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets14.0%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
68.5%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin68.5%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin26.6%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin20.2%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin23.9%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
31.0xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings31.0x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
Price to book5.3x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA19.3x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio6.3x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
0.03safer is higher, placed against 1,436 companies as of 2026-11-07
Debt to equity0.03
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio3.98
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage18.9x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Scoren/a
We do not hold this figure for this company, so there is nothing to place.
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
1.3%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield1.3%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Payout ratio39.0%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio3.0x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.